Drug details
Arexvy (respiratory syncytial virus vaccine, adjuvanted suspension)
type of Vaccines, Inactivated, Viral
Arexvy (respiratory syncytial virus vaccine, adjuvanted) is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals 60 years of age and older.
This drug may have the following side effects:
- injection site pain,
- headache, and
- fatigue,
- muscle pain,
- joint pain.